Published on: January 26, 2018 at 12:00PM Conditions: Breast Cancer; HER2 Gene MutationIntervention: Drug: PyrotinibSponsor: Peking Union Medical CollegeRecruiting http://ift.tt/2Glm3eK
Clinical Trials
Published on: January 26, 2018 at 12:00PM Conditions: Breast Cancer; HER2 Gene MutationIntervention: Drug: PyrotinibSponsor: Peking Union Medical CollegeRecruiting http://ift.tt/2Glm3eK
Published on: January 26, 2018 at 12:00PM Condition: Prostate CancerIntervention: Biological: Bcl-Xl_42-CAF09b vaccineSponsor: Inge Marie SvaneNot yet recruiting http://ift.tt/2rFTcyR
Published on: January 26, 2018 at 12:00PM Condition: Prostate CancerIntervention: Biological: Bcl-Xl_42-CAF09b vaccineSponsor: Inge Marie SvaneNot yet recruiting http://ift.tt/2rFTcyR
Published on: January 26, 2018 at 12:00PM Condition: Prostate CancerIntervention: Biological: Bcl-Xl_42-CAF09b vaccineSponsor: Inge Marie SvaneNot yet recruiting http://ift.tt/2rFTcyR
Published on: January 26, 2018 at 12:00PM Condition: Prostate CancerIntervention: Biological: Bcl-Xl_42-CAF09b vaccineSponsor: Inge Marie SvaneNot yet recruiting http://ift.tt/2rFTcyR
Published on: January 26, 2018 at 12:00PM Conditions: Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal CarcinomaIntervention: Radiation: Computed Tomography Perfusion ImagingSponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI)Not...
Published on: January 26, 2018 at 12:00PM Conditions: Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal CarcinomaIntervention: Radiation: Computed Tomography Perfusion ImagingSponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI)Not...
Published on: January 26, 2018 at 12:00PM Conditions: Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal CarcinomaIntervention: Radiation: Computed Tomography Perfusion ImagingSponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI)Not...
Published on: January 25, 2018 at 12:00PM Condition: Gastric CancerInterventions: Biological: activated DCs; Procedure: radical surgery onlySponsor: LanZhou UniversityRecruiting http://ift.tt/2na3CBa
Published on: January 25, 2018 at 12:00PM Condition: Gastric CancerInterventions: Biological: activated DCs; Procedure: radical surgery onlySponsor: LanZhou UniversityRecruiting http://ift.tt/2na3CBa
Published on: January 25, 2018 at 12:00PM Conditions: Cancer; Gastrointestinal Cancer; Lung Cancer; Urinary Tract Cancer; Prostate CancerIntervention: Behavioral: Diet and antismoking adviceSponsor:...
Published on: January 25, 2018 at 12:00PM Conditions: Cancer; Gastrointestinal Cancer; Lung Cancer; Urinary Tract Cancer; Prostate CancerIntervention: Behavioral: Diet and antismoking adviceSponsor:...
Published on: January 25, 2018 at 12:00PM Conditions: Cancer; Gastrointestinal Cancer; Lung Cancer; Urinary Tract Cancer; Prostate CancerIntervention: Behavioral: Diet and antismoking adviceSponsor:...
Published on: January 25, 2018 at 12:00PM Conditions: Cancer; Gastrointestinal Cancer; Lung Cancer; Urinary Tract Cancer; Prostate CancerIntervention: Behavioral: Diet and antismoking adviceSponsor:...
Published on: January 25, 2018 at 12:00PM Conditions: Malignant Neoplasms of Respiratory and Intrathoracic Organs; Non-small Cell Lung CancerInterventions: Drug: Osimertinib;...
Published on: January 25, 2018 at 12:00PM Condition: Advanced Solid Tumors With HER2 or HER3 AbnormalitiesIntervention: Drug: TAS0728Sponsor: ...
Published on: January 25, 2018 at 12:00PM Condition: Advanced Solid Tumors With HER2 or HER3 AbnormalitiesIntervention: Drug: TAS0728Sponsor: ...
